Conflicts of interest R.M.S. has served as a consultant for, and has received speakers’ honoraria and financial support to perform clinical trials from Almirall, Biofrontera, Energist, Galderma, Intendis, Novartis, Photonamic and Wyeth. The remaining authors declare no conflicts of interest.

L.P. Samorano, L.A. Torezan, J.A. Sanches, Evaluation of the tolerability and safety of a 0.015% ingenol mebutate gel compared to 5% 5-fluorouracil cream for the treatment of facial actinic keratosis: a prospective randomized trial, Journal of the European Academy of Dermatology and Venereology, 2015, 29, 4